Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Zhuang, Z., Liu, Z., Li, J., Wang, X., Xie, P., Xiong, F., Hu, J., Meng, X., Huang, M., Deng, Y., Lan, P., Yu, H., & Luo, Y. (2021). Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer. Journal of Translational Medicine, 19(1). https://doi.org/10.1186/s12967-021-02919-x
Authors:
Zhuokai Zhuang
Zongchao Liu
Juan Li
Xiaolin Wang
Peiyi Xie
Fei Xiong
Jiancong Hu
Xiaochun Meng
Meijin Huang
Yanhong Deng
Ping Lan
Huichuan Yu
Yanxin Luo
Affiliated Authors:
Zongchao Liu
Columbia Affiliation:
Author Keywords:
computed tomography
neoadjuvant treatment
radiomics
rectal cancer
elink
Publication Type:
Article
Unique ID:
10.1186/s12967-021-02919-x
PMID:
34112180
DOI:
10.1186/s12967-021-02919-x
Journal:
Journal of Translational Medicine
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: